Fund Managers
NZVIF has made investment commitments to the following venture capital funds. We have completed a full due diligence on each of these managers and consider that their fund structure and management team is investment grade and in line with standard industry practice.
BioPacific Management Ltd
BioPacificVentures is a NZ$100 million investment fund, focused on life sciences, specialising in the convergence of food and health including prevention.
www.biopacificventures.com or www.directcapital.co.nz
Endeavour i-Cap Ltd
Endeavour Capital’s focus is on developing globally competitive companies based on science and technology innovations. To date Endeavour has made investments across biotechnology, software and medical sectors.
www.ecap.co.nz
iGlobe Treasury Management Ltd
iGlobe Treasury invests into New Zealand technology ventures in the biotechnology, information and communications technology, environmental and conservational technologies, and creative media industries.
www.iglobetreasury.com
No 8 Ventures Management Ltd
No 8 Ventures is a technology venture capital fund manager. Founded in 1999, No8 Ventures has invested in a range of young New Zealand companies, ranging from telco software companies to early stage human pharmaceuticals and biotechnology.
www.no8ventures.co.nz
Pioneer Capital Management Ltd
Pioneer is an investor in early and expansion stage New Zealand companies focused on export and growth in large international markets. Its investment focus is on specialised manufacture and design and information and communications technology.
www.pioneercapital.co.nz
TMT Management Ltd
TMT Ventures is a $100 million corporate venture capital fund investing in the digital economy: communications, technology, e-commerce and media sectors.
www.directcapital.co.nz
What's new...
- Angels invest nearly $50 million in 2009
- Halo Fund to be redesigned
- NZVIF records first surplus and record investment year
- NZVIF commits $4m to Auckland University research commercialisation
- Angel investment at record levels
- New $8m investment partnership targets life sciences and technology
- US academic sees progress in NZ venture capital
